Predicted to enable myosin V binding activity. Predicted to be involved in several processes, including epithelial cell morphogenesis; positive regulation of epithelial cell migration; and pseudopodium organization. Predicted to be located in cytoplasmic vesicle; plasma membrane; and pseudopodium. Orthologous to human RAB25 (RAB25, member RAS oncogene family).
RGD Description
Predicted to enable GTP binding activity; GTPase activity; and myosin V binding activity. Predicted to be involved in several processes, including epithelial cell morphogenesis; positive regulation of epithelial cell migration; and pseudopodium organization. Predicted to be located in cytoplasmic vesicle; plasma membrane; and pseudopodium. Predicted to be active in Golgi apparatus and recycling endosome. Orthologous to human RAB25 (RAB25, member RAS oncogene family); INTERACTS WITH 1-naphthyl isothiocyanate; 17alpha-ethynylestradiol; 2,3,7,8-tetrachlorodibenzodioxine.